Semaglutide is a glucagon-like peptide (GLP-1) which shows great promise for patients who are having difficulty losing weight. Studies have demonstrated that Semaglutide reduced appetite, improved control of eating, and reduced food cravings in addition to improved glycemic control. The greatest weight loss benefits were observed when Semaglutide is used in combination with lifestyle changes, such as improved diet and consistent exercise.
Tirzepatide is a single molecule that activates the body's receptors for GIP and GLP-1 receptors, which are natural incretin hormones. Both receptors are found in areas of the human brain important for appetite regulation. Tirzepatide works by helping individuals feel full on less food, and decreasing food intake and cravings. The greatest weight loss benefits are observed when Tirzepatide is used in combination with lifestyle changes, such as improved diet and consistent exercise.